Viewing StudyNCT00035347



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00035347
Status: COMPLETED
Last Update Posted: 2017-03-10
First Post: 2002-05-02

Brief Title: Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
Sponsor: Pfizer
Organization: Pfizer

Organization Data

Organization: Pfizer
Class: INDUSTRY
Study ID: A0661035
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Director Clinical Trial Disclosure Group
Old Organization: Pfizer Inc

Collaborators